{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:27:36Z","timestamp":1754162856741,"version":"3.41.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03097-8","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T06:17:08Z","timestamp":1753597028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metastatic neuroendocrine carcinoma in inguinal region complicated with membranous nephropathy: a case report"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4179-6182","authenticated-orcid":false,"given":"Xinyun","family":"Qiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9529-5450","authenticated-orcid":false,"given":"Jieyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-2752","authenticated-orcid":false,"given":"Mujie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-8938","authenticated-orcid":false,"given":"Ruitong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-5406","authenticated-orcid":false,"given":"Qiyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,27]]},"reference":[{"key":"3097_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172\u201385. https:\/\/doi.org\/10.1159\/000443167.","journal-title":"Neuroendocrinology"},{"key":"3097_CR2","doi-asserted-by":"publisher","unstructured":"Ronco P, D. BL. H. Membranous nephropathy. Nat Rev Dis Primers. 2021;7:69.https:\/\/doi.org\/10.1038\/s41572-021-00303-z","DOI":"10.1038\/s41572-021-00303-z"},{"key":"3097_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-024-02084-6","author":"D Cozzo","year":"2024","unstructured":"Cozzo D, Orlando F, Bruno M, et al. Minimal change glomerular disease associated with solid neoplasms: a systematic review. J Nephrol. 2024. https:\/\/doi.org\/10.1007\/s40620-024-02084-6.","journal-title":"J Nephrol"},{"key":"3097_CR4","doi-asserted-by":"publisher","unstructured":"Montague E, Hockenhull K, Lamarca A, et al. Duodenal neuroendocrine tumour associated with minimal change glomerulonephritis. BMJ Case Rep. 2019;12(e227987). https:\/\/doi.org\/10.1136\/bcr-2018-227987.","DOI":"10.1136\/bcr-2018-227987"},{"key":"3097_CR5","doi-asserted-by":"publisher","unstructured":"Ashman N, Steele JPC, Sheaff M, et al. Membranous nephropathy resolving with treatment of bronchial carcinoid tumor. Am J Kidney Diseases. 2000;36 https:\/\/doi.org\/10.1053\/ajkd.2000.16214","DOI":"10.1053\/ajkd.2000.16214"},{"key":"3097_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2019.02.010","volume":"74","author":"SH Nasr","year":"2019","unstructured":"Nasr SH, Wehbe E, Said SM, et al. Paraneoplastic cast nephropathy associated with pancreatic mixed Acinar-Neuroendocrine carcinoma: A case report. Am J Kidney Dis. 2019;74:558\u201362. https:\/\/doi.org\/10.1053\/j.ajkd.2019.02.010.","journal-title":"Am J Kidney Dis"},{"key":"3097_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5414\/CNP75042","volume":"1","author":"T Forslund","year":"2011","unstructured":"Forslund T, Kellokumpu I, Elomaa E, et al. Remission of membranous glomerulonephritis after pancreatectomy for pancreatic neuroendocrine neoplasm\u2013 a rare coincidence. Clin Nephrol. 2011;1:42\u20136. https:\/\/doi.org\/10.5414\/CNP75042.","journal-title":"Clin Nephrol"},{"key":"3097_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.pop.2020.08.002","volume":"47","author":"SA Politano","year":"2020","unstructured":"Politano SA, Colbert GB, Hamiduzzaman N. Nephrotic syndrome. Prim Care Clin Office Pract. 2020;47:597\u2013613. https:\/\/doi.org\/10.1016\/j.pop.2020.08.002.","journal-title":"Prim Care: Clin Office Pract"},{"key":"3097_CR9","doi-asserted-by":"publisher","unstructured":"Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103:186\u2013194.https:\/\/doi.org\/10.1159\/000443172","DOI":"10.1159\/000443172"},{"key":"3097_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jons.2017.08.005","volume":"3","author":"N Bisht","year":"2017","unstructured":"Bisht N, Singh S, Sarin A, et al. Neuroendocrine tumor of the inguinal node: a very rare presentation. J Oncological Sci. 2017;3:137\u20139. https:\/\/doi.org\/10.1016\/j.jons.2017.08.005.","journal-title":"J Oncological Sci"},{"key":"3097_CR11","doi-asserted-by":"publisher","unstructured":"Shuttleworth PW, Ullah S, Scott M, et al. Complete spontaneous regression of colorectal cancer: a report of two cases. Cureus. 2023;15:5.https:\/\/doi.org\/10.7759\/cureus.39128","DOI":"10.7759\/cureus.39128"},{"key":"3097_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-017-2761-2","author":"GM Brodeur","year":"2018","unstructured":"Brodeur GM. Spontaneous regression of neuroblastoma. Cell Tissue Res. 2018;372:277\u201386. https:\/\/doi.org\/10.1007\/s00441-017-2761-2."},{"key":"3097_CR13","doi-asserted-by":"publisher","unstructured":"\u017darkovi\u0107 N, Jaganjac M, \u017darkovi\u0107 K, et al. Spontaneous regression of cancer: revealing granulocytes and oxidative stress as the crucial Double-edge sword. Front Bioscience-Landmark. 2022;27:119https:\/\/doi.org\/10.31083\/j.fbl2704119","DOI":"10.31083\/j.fbl2704119"},{"key":"3097_CR14","doi-asserted-by":"publisher","unstructured":"Morandi F, Frassoni F, Ponzoni M, et al. Novel immunotherapeutic approaches for neuroblastoma and malignant melanoma. J Immunol Res. 2018;1\u201312https:\/\/doi.org\/10.1155\/2018\/8097398","DOI":"10.1155\/2018\/8097398"},{"key":"3097_CR15","doi-asserted-by":"publisher","unstructured":"Hill RH, Platt SM, Bersani TA, et al. Regression of a paraganglioma tumor of the orbit. Orbit. 2014;34: 99\u2013102https:\/\/doi.org\/10.3109\/01676830.2014.950290","DOI":"10.3109\/01676830.2014.950290"},{"key":"3097_CR16","doi-asserted-by":"publisher","unstructured":"Rossi RE, Corti F, Pusceddu S, et al. Multidisciplinary approach to the diagnosis of occult primary neuroendocrine neoplasm: a clinical challenge. J Clin Med. 2023;12(5537). https:\/\/doi.org\/10.3390\/jcm12175537.","DOI":"10.3390\/jcm12175537"},{"key":"3097_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10585-014-9672-3","volume":"31","author":"D Kaemmerer","year":"2014","unstructured":"Kaemmerer D, Posorski N, von Eggeling F, et al. The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm.clinical &. Experimental Metastasis. 2014;31:817\u201327. https:\/\/doi.org\/10.1007\/s10585-014-9672-3.","journal-title":"Experimental Metastasis"},{"key":"3097_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-014-9681-2","author":"SK Sherman","year":"2014","unstructured":"Sherman SK, Maxwell JE, Carr JC, et al. Clin Exp Metastasis. 2014;31:935\u201344. https:\/\/doi.org\/10.1007\/s10585-014-9681-2. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors."},{"key":"3097_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1159\/000504370","volume":"110","author":"AM Berner","year":"2020","unstructured":"Berner AM, Pipinikas C, Ryan A, et al. Diagnostic approaches to neuroendocrine neoplasms of unknown primary site. Neuroendocrinology. 2020;110:563\u201373. https:\/\/doi.org\/10.1159\/000504370.","journal-title":"Neuroendocrinology"},{"key":"3097_CR20","doi-asserted-by":"publisher","unstructured":"Liang Y. X. The diagnosis and treatment of G3 neuroendocrine tumors according to the new NCCN guideline. 2022;102:982\u20137https:\/\/doi.org\/10.3760\/cma.j.cn112137-20210826-01943","DOI":"10.3760\/cma.j.cn112137-20210826-01943"},{"key":"3097_CR21","doi-asserted-by":"publisher","unstructured":"Beck LH, Bonegio RGB, Lambeau G, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, New England. J Med. 2009;361: 11\u201321https:\/\/doi.org\/10.1056\/NEJMoa0810457","DOI":"10.1056\/NEJMoa0810457"},{"key":"3097_CR22","doi-asserted-by":"publisher","unstructured":"Efe O, So PNH, Anandh U, et al. An updated review of membranous nephropathy. Indian J Nephrol. 2024;34:105\u201318https:\/\/doi.org\/10.25259\/ijn_317_23","DOI":"10.25259\/ijn_317_23"},{"key":"3097_CR23","doi-asserted-by":"publisher","unstructured":"Cui H, Li C, Li H, et al. Analysis of glomerular IgG subclasses switch in idiopathic membranous nephropathy classified by glomerular phospholipase A2 receptor antigen and serum antibody. Dis Markers. 2021;1\u20137. https:\/\/doi.org\/10.1155\/2021\/9965343.","DOI":"10.1155\/2021\/9965343"},{"key":"3097_CR24","doi-asserted-by":"publisher","unstructured":"Nallathambi N, Chinnadurai A. Carboplatin-Induced hematuria with obstructive acute kidney injury. Cureus. 2024;16(4). https:\/\/doi.org\/10.7759\/cureus.58931.","DOI":"10.7759\/cureus.58931"},{"key":"3097_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000497336","volume":"109","author":"M Frizziero","year":"2019","unstructured":"Frizziero M, Spada F, Lamarca A, et al. Carboplatin in combination with oral or intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated neuroendocrine carcinomas. Neuroendocrinology. 2019;109:100\u201312. https:\/\/doi.org\/10.1159\/000497336.","journal-title":"Neuroendocrinology"},{"key":"3097_CR26","doi-asserted-by":"publisher","unstructured":"Betancor T, Vi\u00f1a MM, Ramos S, et al. Oral Etoposide in Merkel cell carcinoma. Eur J Hosp Pharm. 2017;24: 244\u20135https:\/\/doi.org\/10.1136\/ejhpharm-2016-001194","DOI":"10.1136\/ejhpharm-2016-001194"},{"key":"3097_CR27","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3892\/mco.2015.628","volume":"3","author":"M Caubet","year":"2015","unstructured":"Caubet M, Dobi E, Pozet A, et al. Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study. Mol Clin Oncol. 2015;3:1208\u201312. https:\/\/doi.org\/10.3892\/mco.2015.628.","journal-title":"Mol Clin Oncol"},{"key":"3097_CR28","doi-asserted-by":"publisher","unstructured":"Ali AS, Gr\u00f6nberg M, Langer SW, et al. Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Med Oncol. 35;2018.https:\/\/doi.org\/10.1007\/s12032-018-1103-x","DOI":"10.1007\/s12032-018-1103-x"},{"key":"3097_CR29","volume-title":"Guidelines of Chinese society of clinical oncology (CSCO):Neuroendocrine neoplasms","author":"Chinese Society of Clinical Oncology Guidelines Working Committee","year":"2024","unstructured":"Chinese Society of Clinical Oncology Guidelines Working Committee. Guidelines of Chinese society of clinical oncology (CSCO):Neuroendocrine neoplasms. China: People\u2019s Medical Publishing House; 2024."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03097-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03097-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03097-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:04:05Z","timestamp":1753898645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03097-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03097-8","relation":{"references":[{"id-type":"doi","id":"10.1007\/s00441-017-2761-2","asserted-by":"subject"},{"id-type":"doi","id":"10.1007\/s10585-014-9681-2","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,7,27]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was ethically approved by the First Affiliated Hospital of Nanjing Medical University. Prior to participation, participant was duly informed of her rights and responsibilities and provided explicit written consent. The study was conducted in.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"agreement with the guidelines governing research involving human participants, as outlined by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have obtained written consent to publish the images\/details of the individual(s) included in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1417"}}